Robarts Research Institute engages in the provision of medical research facilities for investigating various diseases such as diabetes, heart and stroke, Alzheimer's, and cancer diseases. The company was founded by Henry Barnett in 1986 and is headquartered in London, Canada.

Wellstat Biologics Corp. is a private company headquartered in Gaithersburg, MD, that operates as development and commercialization of biological agents.

Bavarian Nordic A/S focuses on the development, manufacturing and commercialization of cancer immunotherapies and vaccines for infectious diseases. It specializes in cancer immunotherapy which includes cancer pipeline, which focuses on therapeutic vaccines for breast, lung, ovarian and prostate cancer. Its products include IMVAMUNE for Ebola, HPV, HBV, and HIV diseases. The company was founded in 1994 and is headquartered in Kvistgaard, Denmark.

Systems Oncology develops cancer treatment drugs to accelerate scientific innovations into breakthrough cancer therapies. Equipped with advanced cognitive computing technologies, the company is able to aggregate and mine disparate types of biomedical datasets to reveal novel contextual vulnerabilities in cancer and collaborate with leading universities to exploit those vulnerabilities with cutting-edge agents. Founded in 2015, Systems Oncology is headquartered in Scottsdale, Arizona.

Discovers and develops novel therapeutics for inflammatory disorders

Viron is a biopharmaceutical company that uses breakthrough discovery and novel technologies to identify and develop patent-pending high-value therapies for currently unarguable porosome protein and lipid targets in cancer, Alzheimer's, diabetes, neurological, digestive, and immune disorders. Breakthroughs in genomics and gene editing technologies, stem cell biology, patient-derived organoids, cryo-electron microscopy, synthetic biology, small molecule screening, and image analysis using AI machine learning and high-throughput screening have transformed the drug discovery landscape.

The Institut national de la recherche agronomique (INRA, pronounced [inʁa]; English: National Institute of Agricultural Research) is a French public research institute dedicated to agricultural science. It was founded in 1946 and is a Public Scientific and Technical Research Establishment under the joint authority of the Ministries of Research and Agriculture.

Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia.

Bavarian Nordic, Inc. engages in researching and manufacturing drugs to treat cancer. The company is headquartered in Morrisville, NC.

Provides fully integrated contract manufacturing services to medical device manufacturers worldwide in the cardiovascular, endoscopy and orthopedic markets

ViroCure, Inc. finds and develops viruses to treat terminal cancer illnesses with no current cure regimen. The firm develops oncolytic viral agents, vaccines and others. The company was founded by Manbok Kim in June 2016 and is headquartered in Seoul, South Korea.

Arizona Board of Regents oversees college activities. The company was founded in 1864 and is headquartered in Phoenix, AZ.

UNM Rainforest Innovations (Venture Capital) (UNM Rainforest Innovations) is a venture capital a subsidiary of University of New Mexico Foundation, Inc. founded in 2014. The firm is headquartered in Albuquerque, New Mexico.

Bioventures LLC is an American private company located in Tulsa, OK, that develops pharmaceutical products. The firm was founded in 2004.

Je Il Pharm Co., Ltd. is a private company headquartered in Daegu, the South Korea, that manufactures and sells pharmaceutical products.

Cloud Pharmaceuticals is committed to improving health and well-being through the computational design and rapid development of new therapies. We use a proprietary design process that combines artificial intelligence (AI) and cloud computing to search virtual molecular space and applies along sophisticated molecular modeling to design novel drugs that are well-qualified for development from the outset and have original composition of matter IP. The process enables faster drug development progress at lower cost and a higher success rate and better targeting of hard-to-drug indications. Our approach amplifies the power of cloud computing and AI to radically improve drug discovery and design. We partner at all stages of drug development – from discovery through the clinic – and are building an extensive product pipeline that spans a wide range of indications.